CyanoCapture
Using the world’s fastest photosynthetic microbe to capture CO2 and turn it into insulin at radically low cost.
The problem
Capturing CO2 from flue gases is costly and often not economically viable. Meanwhile, the carbon credit market has lagged behind expectations, forcing companies to seek additional revenue streams.
The solution
Cyanocapture has engineered cyanobacteria strains that fix carbon at rates 300% higher than natural strains. They convert the biomass into two key products: graphite and high-value recombinant proteins. Cyanocapture offers a sustainable, economically viable path to reducing industrial CO2 emissions by boosting carbon capture efficiency and delivering in-demand outputs.
There are no related news
